Abstract
Suicide is a leading cause of death, and presently, there is no definitive clinical indicator of future suicide behaviors. Anhedonia, a transdiagnostic symptom reflecting diminished ability to experience pleasure, has recently emerged as a risk factor for suicidal thoughts and behaviors (STBs). This overview, therefore, has the following aims. First, prior research relating anhedonia to STBs will be reviewed, with a particular focus on clarifying whether anhedonia is more closely associated with suicidal thoughts versus behaviors. Second, the National Institute of Mental Health’s Research Domain Criteria Positive Valence Systems provide a useful heuristic to probe anhedonia across different units of analysis, including clinical symptoms, behaviors, neural mechanisms, and molecular targets. Accordingly, anhedonia-related constructs linked to STBs will be detailed as well as promising next steps for future research. Third, although anhedonia is not directly addressed in leading suicide theories, this review will provide potential inroads to explore anhedonia within diathesis-stress and interpersonal suicide frameworks. Last, novel approaches to treat anhedonia as a means of reducing STBs will be examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(CDC) (2019) Web-based injury statistis query and reporting system (WISQARS): fatal injury reports, national and regional, 1981–2019. https://www.cdc.gov/injury/wisqars/fatal.html
Allen NB, Nelson BW, Brent D, Auerbach RP (2019) Short-term prediction of suicidal thoughts and behaviors in adolescents: can recent developments in technology and computational science provide a breakthrough? J Affect Disord 250:163–169
Amlung M, Marsden E, Holshausen K, Morris V, Patel H, Vedelago L et al (2019) Delay discounting as a transdiagnostic process in psychiatric disorders: a meta-analysis. JAMA Psychiat 76(11):1176–1186
Auerbach RP, Millner AJ, Stewart JG, Esposito EC (2015) Identifying differences between depressed adolescent suicide ideators and attempters. J Affect Disord 186:127–133
Auerbach RP, Pisoni A, Bondy E, Kumar P, Stewart JG, Yendiki A et al (2017) Neuroanatomical prediction of anhedonia in adolescents. Neuropsychopharmacology 42(10):2087–2095
Auerbach RP, Pagliaccio D, Allison GO, Alqueza KL, Alonso MF (2021) Neural correlates associated with suicide and nonsuicidal self-injury in youth. Biol Psychiatry 89(2):119–133
Auerbach RP, Srinivasan A, Kirshenbaum JS, Mann JJ, Shankman SA (2022a) Geolocation features differentiate healthy from remitted depressed adults. J Psychopathol Clin Sci. https://doi.org/10.1037/abn0000742
Auerbach RP, Pagliaccio D, Hubbard NA, Frosch I, Kremens R, Cosby E, Jones R, Siless V, Lo N, Henin A, Hofmann SG, Gabrieli JDE, Yendiki A, Whitfield-Gabrieli S, Pizzagalli DA (2022b) Reward-related neural circuitry in depressed and anxious adolescents: a human connectome project. J Am Acad Child Adolesc Psychiatry 61(2):308–320
Baek K, Kwon J, Chae J-H, Chung YA, Kralik JD, Min J-A et al (2017) Heightened aversion to risk and loss in depressed patients with a suicide attempt history. Sci Rep 7(1):11228
Ballard ED, Vande Voort JL, Luckenbaugh DA, Machado-Vieira R, Tohen M, Zarate CA (2016) Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study. Bipolar Disord 18(4):363–372
Ballard ED, Wills K, Lally N, Richards EM, Luckenbaugh DA, Walls T et al (2017) Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. J Affect Disord 218:195–200
Berridge KC, Kringelbach ML (2015) Pleasure systems in the brain. Neuron 86(3):646–664
Bonanni L, Gualtieri F, Lester D, Falcone G, Nardella A, Fiorillo A et al (2019) Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina 55(8):458
Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW (1997a) Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 769(1):135–140
Bowden C, Theodorou AE, Cheetham SC, Lowther S, Katona CL, Crompton MR et al (1997b) Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 752(1–2):227–233
Bressan RA, Crippa JA (2005) The role of dopamine in reward and pleasure behaviour–review of data from preclinical research. Acta Psychiatr Scand 111:14–21
Brezo J, Klempan T, Turecki G (2008) The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am 31(2):179–203
Bryan CJ, Bryan AO (2021) Delayed reward discounting and increased risk for suicide attempts among U.S. adults with probable PTSD. J Anxiety Disord 81:102414
Burani K, Brush C, Gallyer A, Joiner T, Nelson B, Hajcak G (2021) Maternal suicidality interacts with blunted reward processing to prospectively predict increases in depressive symptoms in 8-to-14-year-old girls. Int J Psychophysiol 170:67–74
Carlson JM, Foti D, Mujica-Parodi LR, Harmon-Jones E, Hajcak G (2011) Ventral striatal and medial prefrontal BOLD activation is correlated with reward-related electrocortical activity: a combined ERP and fMRI study. Neuroimage 57(4):1608–1616
Chong TT, Bonnelle V, Manohar S, Veromann KR, Muhammed K, Tofaris GK et al (2015) Dopamine enhances willingness to exert effort for reward in Parkinson's disease. Cortex 69:40–46
Conner KR, Bridge JA, Davidson DJ, Pilcher C, Brent DA (2019) Metaanalysis of mood and substance use disorders in proximal risk for suicide deaths. Suicide Life Threat Behav 49(1):278–292
Conway CC, Li YI, Starr LR (2019) Trait anhedonia is a transdiagnostic correlate of internalizing problems during adolescence. J Res Pers 81:56–63
Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ (2016) Treatment for anhedonia: a neuroscience driven approach. Depress Anxiety 33(10):927–938
Craske MG, Meuret AE, Ritz T, Treanor M, Dour H, Rosenfield D (2019) Positive affect treatment for depression and anxiety: a randomized clinical trial for a core feature of anhedonia. J Consult Clin Psychol 87(5):457
Cuthbert BN (2014) The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13(1):28–35
Dai Z, Harrow S-E, Song X, Rucklidge JJ, Grace RC (2016) Gambling, delay, and probability discounting in adults with and without ADHD. J Atten Disord 20(11):968–978
Delgado MR, Nystrom LE, Fissell C, Noll D, Fiez JA (2000) Tracking the hemodynamic responses to reward and punishment in the striatum. J Neurophysiol 84(6):3072–3077
Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35(1):68–77
DeWilde KE, Levitch CF, Murrough JW, Mathew SJ, Iosifescu DV (2015) The promise of ketamine for treatment-resistant depression: current evidence and future directions. Ann N Y Acad Sci 1345(1):47
Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793–802
Dombrovski AY, Clark L, Siegle GJ, Butters MA, Ichikawa N, Sahakian BJ et al (2010) Reward/punishment reversal learning in older suicide attempters. Am J Psychiatry 167(6):699–707
Dombrovski AY, Szanto K, Siegle GJ, Wallace ML, Forman SD, Sahakian B et al (2011) Lethal forethought: delayed reward discounting differentiates high- and low-lethality suicide attempts in old age. Biol Psychiatry 70(2):138–144
Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF, Aizenstein H (2012) The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med 42(6):1203–1215
Dombrovski AY, Szanto K, Clark L, Reynolds CF, Siegle GJ (2013) Reward signals, attempted suicide, and impulsivity in late-life depression. JAMA Psychiat 70(10):1
Dougherty DM, Mathias CW, Marsh-Richard DM, Prevette KN, Dawes MA, Hatzis ES et al (2009) Impulsivity and clinical symptoms among adolescents with non-suicidal self-injury with or without attempted suicide. Psychiatry Res 169(1):22–27
Douma EH, de Kloet ER (2020) Stress-induced plasticity and functioning of ventral tegmental dopamine neurons. Neurosci Biobehav Rev 108:48–77
Dubol M, Trichard C, Leroy C, Sandu A-L, Rahim M, Granger B et al (2018) Dopamine transporter and reward anticipation in a dimensional perspective: a multimodal brain imaging study. Neuropsychopharmacology 43(4):820–827
Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S et al (2018) Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety 35(5):382–392
Ducasse D, Dubois J, Jaussent I, Azorin JM, Etain B, Gard S et al (2021) Association between anhedonia and suicidal events in patients with mood disorders: a 3-year prospective study. Depress Anxiety 38(1):17–27
Eisenlohr-Moul TA, Miller AB, Giletta M, Hastings PD, Rudolph KD, Nock MK et al (2018) HPA axis response and psychosocial stress as interactive predictors of suicidal ideation and behavior in adolescent females: a multilevel diathesis-stress framework. Neuropsychopharmacology 43(13):2564–2571
Fawcett J, Scheftner WA, Fogg L, Clark DC, Young MA, Hedeker D et al (1990) Time-related predictors of suicide in major affective disorder. Am J Psychiatry 147(9):1189–1194
Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X et al (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21(10):1358–1365
Fields SA, Lange K, Ramos A, Thamotharan S, Rassu F (2014) The relationship between stress and delay discounting. Behav Pharmacol 25(5 and 6):434–444
Fields SA, Ramos A, Reynolds BA (2015) Delay discounting and health risk behaviors: the potential role of stress. Curr Opin Psychol 5:101–105
Fitzgerald ML, Kassir SA, Underwood MD, Bakalian MJ, Mann JJ, Arango V (2017) Dysregulation of striatal dopamine receptor binding in suicide. Neuropsychopharmacology 42(4):974–982
Flament M, Loas G, Godefroy OK, Krystkowiak P (2011) Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 23(4):E32
Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X et al (2017) Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull 143(2):187
Gabbay V, Ely BA, Li Q, Bangaru SD, Panzer AM, Alonso CM et al (2013) Striatum-based circuitry of adolescent depression and anhedonia. J Am Acad Child Adolesc Psychiatry 52(6):628–41 e13
Gallyer AJ, Dougherty SP, Burani K, Albanese BJ, Joiner TE, Hajcak G (2021) Suicidal thoughts, behaviors, and event-related potentials: a systematic review and meta-analysis. Psychophysiology 58(12):e13939
Galvan A (2010) Adolescent development of the reward system. Front Hum Neurosci 4:6
Glenn CR, Cha CB, Kleiman EM, Nock MK (2017) Understanding suicide risk within the research domain criteria (RDoC) framework: insights, challenges, and future research considerations. Clin Psychol Sci 5(3):568–592
Glenn CR, Kleiman EM, Cha CB, Deming CA, Franklin JC, Nock MK (2018) Understanding suicide risk within the research domain criteria (RDoC) framework: a meta-analytic review. Depress Anxiety 35(1):65–88
Glimcher PW (2011) Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A 108(Suppl 3):15647–15654
Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013) Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74(2):130–136
Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41(1):1–24
Green MF, Horan WP, Barch DM, Gold JM (2015) Effort-based decision making: a novel approach for assessing motivation in schizophrenia. Schizophr Bull 41(5):1035–1044
Grunebaum MF, Galfalvy HC, Choo T-H, Keilp JG, Moitra VK, Parris MS et al (2018) Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 175(4):327–335
Hadlaczky G, Hökby S, Mkrtchian A, Wasserman D, Balazs J, Machín N et al (2018) Decision-making in suicidal behavior: the protective role of loss aversion. Front Psych 9:116
Hart KL, Brown HE, Roffman JL, Perlis RH (2019) Risk tolerance measured by probability discounting among individuals with primary mood and psychotic disorders. Neuropsychology 33(3):417
Hawes M, Galynker I, Barzilay S, Yaseen ZS (2018) Anhedonia and suicidal thoughts and behaviors in psychiatric outpatients: the role of acuity. Depress Anxiety 35(12):1218–1227
Helfinstein SM, Kirwan ML, Benson BE, Hardin MG, Pine DS, Ernst M et al (2013) Validation of a child-friendly version of the monetary incentive delay task. Soc Cogn Affect Neurosci 8(6):720–726
Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM et al (2015) Effort-based decision-making paradigms for clinical trials in schizophrenia: part 2-external validity and correlates. Schizophr Bull 41(5):1055–1065
Ilango A, Kesner AJ, Keller KL, Stuber GD, Bonci A, Ikemoto S (2014) Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci 34(3):817–822
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167(7):748–751
Janelidze S, Mattei D, Westrin Å, Träskman-Bendz L, Brundin L (2011) Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25(2):335–339
Ji X, Zhao J, Li H, Pizzagalli DA, Law S, Lin P et al (2021) From motivation, decision-making to action: an fMRI study on suicidal behavior in patients with major depressive disorder. J Psychiatr Res 139:14–24
Joiner TE Jr (2005) Why people die by suicide. Harvard University Press, Cambridge, p 304
Jollant F, Lawrence NS, Olie E, O'Daly O, Malafosse A, Courtet P et al (2010) Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage 51(3):1275–1281
Kelley NJ, Schmeichel BJ (2015) Thinking about death reduces delay discounting. PLoS One 10(12):e0144228
Kelly DL, Shim J-C, Feldman SM, Yu Y, Conley RR (2004) Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res 38(5):531–536
Keren H, O'Callaghan G, Vidal-Ribas P, Buzzell GA, Brotman MA, Leibenluft E et al (2018) Reward processing in depression: a conceptual and meta-analytic review across fMRI and EEG studies. Am J Psychiatry:appiajp201817101124
Kia-Keating BM, Glatt SJ, Tsuang MT (2007) Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 144B(8):1048–1053
Klein-Flugge MC, Hunt LT, Bach DR, Dolan RJ, Behrens TE (2011) Dissociable reward and timing signals in human midbrain and ventral striatum. Neuron 72(4):654–664
Klonsky ED, May AM (2015) The three-step theory (3ST): a new theory of suicide rooted in the “ideation-to-action” framework. Int J Cogn Ther 8(2):114–129
Knutson B, Westdorp A, Kaiser E, Hommer D (2000) FMRI visualization of brain activity during a monetary incentive delay task. NeuroImage 12:20–27. https://doi.org/10.1006/nimg.2000.0593
Lally N, Nugent A, Luckenbaugh D, Ameli R, Roiser J, Zarate C (2014) Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Transl Psychiatry 4(10):e469
Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA Jr (2015) Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. J Psychopharmacol 29(5):596–607
Larkin GL, Beautrais AL (2011) A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14(8):1127–1131
Lee Y, Mansur RB, Brietzke E, Carmona NE, Subramaniapillai M, Pan Z et al (2020) Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression. Brain Behav Immun 88:631–639
Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28(02):45–50
Levinson AR, Speed BC, Infantolino ZP, Hajcak G (2017) Reliability of the electrocortical response to gains and losses in the doors task. Psychophysiology 54(4):601–607
Liu RT, Vassileva J, Gonzalez R, Martin EM (2012) A comparison of delay discounting among substance users with and without suicide attempt history. Psychol Addict Behav 26(4):980
Llerena K, Park SG, Couture SM, Blanchard JJ (2012) Social anhedonia and affiliation: examining behavior and subjective reactions within a social interaction. Psychiatry Res 200(2–3):679–686
Lloyd K, Dayan P (2016) Safety out of control: dopamine and defence. Behav Brain Funct 12(1):15
Loas G (2007) Anhedonia and suicide: a 6.5-yr. follow-up study of patients hospitalised for a suicide attempt. Psychol Rep 100(1):183–190
Loas G (2014) Anhedonia: a comprehensive handbook, vol II. Springer, pp 247–253
Loas G, Lefebvre G, Rotsaert M, Englert Y (2018) Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians. PLoS One 13(3):e0193619
Loas G, Solibieda A, Rotsaert M, Englert Y (2019) Suicidal ideations among medical students: the role of anhedonia and type D personality. PLoS One 14(6):e0217841
Luking KR, Luby JL, Barch DM (2014) Kids, candy, brain and behavior: age differences in responses to candy gains and losses. Dev Cogn Neurosci 9:82–92
Luking KR, Pagliaccio D, Luby JL, Barch DM (2016) Do losses loom larger for children than adults? Emotion 16(3):338–348
Luking KR, Infantolino ZP, Nelson BD, Hajcak G (2019) Age-typical changes in neural reward response are moderated by maternal anhedonia. Psychophysiology:e13358
Manchia M, Pisanu C, Squassina A, Carpiniello B (2020) Challenges and future prospects of precision medicine in psychiatry. Pharmacogenomics Pers Med 13:127
Mann J, Waternaux C, Haas GL, Malone KM (1999) Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156(2):181–189
Mann JJ, Michel CA, Auerbach RP (2021) Improving suicide prevention through evidence-based strategies: a systematic review. Am J Psychiatry:appi.ajp. 2020.20060864
Mathias CW, Dougherty DM, James LM, Richard DM, Dawes MA, Acheson A et al (2011) Intolerance to delayed reward in girls with multiple suicide attempts. Suicide Life Threat Behav 41(3):277–286
May JC, Delgado MR, Dahl RE, Stenger VA, Ryan ND, Fiez JA et al (2004) Event-related functional magnetic resonance imaging of reward-related brain circuitry in children and adolescents. Biol Psychiatry 55(4):359–366
McHugh CM, Chun Lee RS, Hermens DF, Corderoy A, Large M, Hickie IB (2019) Impulsivity in the self-harm and suicidal behavior of young people: a systematic review and meta-analysis. J Psychiatr Res 116:51–60
Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34
Mullins N, Kang J, Campos AI, Coleman JRI, Edwards AC, Galfalvy H et al (2022) Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors. Biol Psychiatry 91(3):313–327
Murrough JW, Soleimani L, DeWilde K, Collins K, Lapidus K, Iacoviello B et al (2015) Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 45(16):3571–3580
Niv Y, Daw ND, Joel D, Dayan P (2007) Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) 191(3):507–520
Nock MK, Kazdin AE (2002) Examination of affective, cognitive, and behavioral factors and suicide-related outcomes in children and young adolescents. J Clin Child Adolesc Psychol 31(1):48–58
Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A et al (2008) Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 192(2):98–105
Nordentoft M, Mortensen PB, Pedersen CB (2011) Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 68(10):1058–1064
Olie E, Ding Y, Le Bars E, de Champfleur NM, Mura T, Bonafe A et al (2015) Processing of decision-making and social threat in patients with history of suicidal attempt: a neuroimaging replication study. Psychiatry Res 234(3):369–377
Osman A, Bagge CL, Gutierrez PM, Konick LC, Kopper BA, Barrios FX (2001) The suicidal behaviors questionnaire-revised (SBQ-R): validation with clinical and nonclinical samples. Assessment 8(4):443–454
Paul E (2018) Proximally-occurring life events and the first transition from suicidal ideation to suicide attempt in adolescents. J Affect Disord 241:499–504
Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T et al (2016) Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. J Clin Invest 126(9):3336–3350
Pelizza L, Ferrari A (2009) Anhedonia in schizophrenia and major depression: state or trait? Ann Gen Psychiatry 8:22
Perrain R, Dardennes R, Jollant F (2021) Risky decision-making in suicide attempters, and the choice of a violent suicidal means: an updated meta-analysis. J Affect Disord 280(Pt A):241–249
Pettorruso M, d'Andrea G, Martinotti G, Cocciolillo F, Miuli A, Di Muzio I et al (2020) Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder. Clin Biol Correlates Brain Sci 10(8)
Pizzagalli DA (2014) Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10:393–423
Pizzagalli DA, Berretta S, Wooten D, Goer F, Pilobello KT, Kumar P et al (2019) Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: in vivo positron emission tomography and postmortem evidence. JAMA Psychiat 76(8):854–861
Price RB, Nock MK, Charney DS, Mathew SJ (2009) Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66(5):522–526
Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM et al (2015) Effort-based decision-making paradigms for clinical trials in schizophrenia: part 1-psychometric characteristics of 5 paradigms. Schizophr Bull 41(5):1045–1054
Richard-Devantoy S, Berlim MT, Jollant F (2014) A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders. Psychol Med 44(8):1663–1673
Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH (2016) Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev 65:21–35
Roy A, Agren H, Pickar D, Linnoila M, Doran AR, Cutler NR, Paul SM (1986) Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry 143(12):1539–1545
Roy A, De Jong J, Linnoila M (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: a 5-year follow-up study. Arch Gen Psychiatry 46(7):609–612
Sagud M, Tudor L, Šimunić L, Jezernik D, Madžarac Z, Jakšić N et al (2021) Physical and social anhedonia are associated with suicidality in major depression, but not in schizophrenia. Suicide Life Threat Behav 51(3):446–454
Sandman CF, Craske MG (2022) Psychological treatments for anhedonia. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2021_291
Sastre-Buades A, Alacreu-Crespo A, Courtet P, Baca-Garcia E, Barrigon ML (2021) Decision-making in suicidal behavior: a systematic review and meta-analysis. Neurosci Biobehav Rev 131:642–662
Sauder CL, Derbidge CM, Beauchaine TP (2016) Neural responses to monetary incentives among self-injuring adolescent girls. Dev Psychopathol 28(1):277–291
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al (2008) Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33(2):368–377
Schmaal L, van Harmelen A-L, Chatzi V, Lippard ETC, Toenders YJ, Averill LA et al (2020) Imaging suicidal thoughts and behaviors: a comprehensive review of 2 decades of neuroimaging studies. Mol Psychiatry 25(2):408–427
Schultz W (2010) Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 6:24
Shneidman ES (1993) Commentary: suicide as psychache. J Nerv Ment Dis 181(3):145–147
Stewart JG, Glenn CR, Esposito EC, Cha CB, Nock MK, Auerbach RP (2017a) Cognitive control deficits differentiate adolescent suicide ideators from attempters. J Clin Psychiatry 78(6):e614–ee21
Stewart JG, Esposito EC, Glenn CR, Gilman SE, Pridgen B, Gold J et al (2017b) Adolescent self-injurers: comparing non-ideators, suicide ideators, and suicide attempters. J Psychiatr Res 84:105–112
Stewart JG, Polanco-Roman L, Duarte CS, Auerbach RP (2019a) Neurocognitive processes implicated in adolescent suicidal thoughts and behaviors: applying an rdoc framework for conceptualizing risk. Curr Behav Neurosci Rep 6(4):188–196
Stewart JG, Shields GS, Esposito EC, Cosby EA, Allen NB, Slavich GM et al (2019b) Life stress and suicide in adolescents. J Abnorm Child Psychol 47(10):1707–1722
Struhal W, Guger M, Hödl S, Ung S-C, Bach M, Ransmayr G (2012) Attempted suicide under high dose dopaminergic therapy including apomorphine. Wien Klin Wochenschr 124(13–14):461–463
Suda A, Kawanishi C, Kishida I, Sato R, Yamada T, Nakagawa M et al (2009) Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population. Neuropsychobiology 59(2):130–134
Sugama S, Kakinuma Y (2016) Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: possible pathogenetic loci for depression involved in Parkinson's disease. Neurosci Res 111:48–55
Träskman L, Asberg M, Bertilsson L, Sjöstrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38(6):631–636
Treadway MT (2016) The neurobiology of motivational deficits in depression – an update on candidate pathomechanisms. In: Simpson EH, Balsam PD (eds) Behavioral neuroscience of motivation. Springer, Cham, pp 337–355
Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35(3):537–555
Treadway MT, Zald DH (2013) Parsing anhedonia: translational models of reward-processing deficits in psychopathology. Curr Dir Psychol Sci 22(3):244–249
Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH (2009) Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One 4(8):e6598
Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012a) Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121(3):553–558
Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS et al (2012b) Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci 32(18):6170–6176
Tsypes A, Owens M, Hajcak G, Gibb BE (2017) Neural responses to gains and losses in children of suicide attempters. J Abnorm Psychol 126(2):237–243
Tsypes A, Owens M, Gibb BE (2019) Blunted neural reward responsiveness in children with recent suicidal ideation. Clin Psychol Sci 7(5):958–968
Tsypes A, Owens M, Gibb BE (2021) Reward responsiveness in suicide attempters: an electroencephalography/event-related potential study. Biol Psychiatry Cogn Neurosci Neuroimaging 6(1):99–106
Tsypes A, Szanto K, Bridge JA, Brown VM, Keilp JG, Dombrovski AY (2022) Delay discounting in suicidal behavior: myopic preference or inconsistent valuation? J Psychopathol Clin Sci 131(1):34–44
van Heeringen K (2012) Stress-diathesis model of suicidal behavior. Frontiers in neuroscience, 51st edn. CRC Press
van Heeringen K, Mann JJ (2014) The neurobiology of suicide. Lancet Psychiatry 1(1):63–72
Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE Jr (2010) The interpersonal theory of suicide. Psychol Rev 117(2):575–600
Vanyukov PM, Szanto K, Hallquist MN, Siegle GJ, Reynolds CF 3rd, Forman SD et al (2016) Paralimbic and lateral prefrontal encoding of reward value during intertemporal choice in attempted suicide. Psychol Med 46(2):381–391
Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H (2011) Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci 31(46):16597–16602
Whitton AE, Treadway MT, Pizzagalli DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28(1):7–12
WHO (2019) Suicide worldwide in 2019: Global health estimates. https://www.who.int/publications/i/item/9789240026643
Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A et al (2018) The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 175(2):150–158
Winer ES, Drapeau CW, Veilleux JC, Nadorff MR (2016) The association between anhedonia, suicidal ideation, and suicide attempts in a large student sample. Arch Suicide Res 20(2):265–272
Wise RA (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14(2–3):169–183
Yang X, Wang D, Liu S, Liu G, Harrison P (2020a) Stress and suicidal ideation: the role of state or trait anhedonia in a moderated mediation model. Suicide Life Threat Behav 50(2):502–514
Yang X, Yuan X, Liu G, Harrision P (2020b) The specific roles of loss of interest and loss of pleasure in recent suicidal ideation. Arch Suicide Res:1–10
Yang X, Tian K, Wang D, Liu G, Liu X, Harrison P (2021) State anhedonia and suicidal ideation in adolescents. Crisis 42(4):247–254
Yaseen ZS, Galynker II, Briggs J, Freed RD, Gabbay V (2016) Functional domains as correlates of suicidality among psychiatric inpatients. J Affect Disord 203:77–83
Yen S, Weinstock L, Andover M, Sheets E, Selby E, Spirito A (2013) Prospective predictors of adolescent suicidality: 6-month post-hospitalization follow-up. Psychol Med 43(5):983–993
Yin L, Xu X, Chen G, Mehta ND, Haroon E, Miller AH et al (2019) Inflammation and decreased functional connectivity in a widely-distributed network in depression: centralized effects in the ventral medial prefrontal cortex. Brain Behav Immun 80:657–666
Yorbik O, Birmaher B, Axelson D, Williamson DE, Ryan ND (2004) Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. J Clin Psychiatry 65(12):1654–1659
Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al (2012) Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71(11):939–946
Zielinski MJ, Veilleux JC, Winer ES, Nadorff MR (2017) A short-term longitudinal examination of the relations between depression, anhedonia, and self-injurious thoughts and behaviors in adults with a history of self-injury. Compr Psychiatry 73:187–195
Acknowledgments
RPA (U01 MH116923, R01 MH119771) and DP (R01 MH126181) were partially supported through funding from the National Institute of Mental Health. RPA and DP also received support through the Tommy Fuss Fund, and DP received support through the American Foundation for Suicide Prevention (YIG-0-145-20). JSK was supported through the Bender-Fishbein Research Award in Child Psychiatry as well as a training fellowship awarded to the Division of Child and Adolescent Psychiatry at Columbia University (T32 MH016434-42). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Dr. Auerbach is an unpaid scientific advisor for Ksana Health. DP and JSK do not have any biomedical financial interests or potential conflicts of interest.
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Auerbach, R.P., Pagliaccio, D., Kirshenbaum, J.S. (2022). Anhedonia and Suicide. In: Pizzagalli, D.A. (eds) Anhedonia: Preclinical, Translational, and Clinical Integration. Current Topics in Behavioral Neurosciences, vol 58. Springer, Cham. https://doi.org/10.1007/7854_2022_358
Download citation
DOI: https://doi.org/10.1007/7854_2022_358
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09682-2
Online ISBN: 978-3-031-09683-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)